Clinical Trials Directory

Trials / Unknown

UnknownNCT03566329

Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension

Control of Emergence Hypertension After Craniotomy: Comparison Between the Efficacy of Magnesium Sulphate and Lidocaine Infusion (Randomized Controlled Study)

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Ahmed Mohamed ELbadawy · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Post-craniotomy emergence hypertension is a common phenomenon that may predispose to development of intracranial hematoma and cerebral edema.The aim of this study is to compare the safety and efficacy of Mgso4 versus lidocaine infusion for control of emergence hypertension after craniotomy.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium sulphateMagnesium sulphate 50 mg/kg over 10 minutes loading followed by 15mg/kg/hr infusion. .
DRUGLidocaine Hydrochloridelidocaine hydrochloride 1.5mg/kg loading followed by 2mg/kg/hr infusion
DRUGNormal salineNormal saline infusion with the same rate of infusion as the study drugs

Timeline

Start date
2018-07-10
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2018-06-25
Last updated
2019-08-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03566329. Inclusion in this directory is not an endorsement.

Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension (NCT03566329) · Clinical Trials Directory